Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice

Experimental Neurology

Volumn 190, Issue 1, 2004, Pages 245-253

  Herber, Donna L ^a   Roth, Lisa M ^a   Wilson, David ^a   Wilson, Nedda ^a   Mason, Jerimiah E ^a   Morgan, Dave ^a   Gordon, Marcia N ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b 12901 Bruce B D   (United States)

Author keywords

Alzheimer's; Amyloid; Astrocyte; Inflammation; Lipopolysaccharide; Microglia

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CD45 ANTIGEN; FC RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; HIPPOCAMPUS; INJECTIONS; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; MICROGLIA; TIME FACTORS;

EID: 5044222305     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.07.007     Document Type: Article

References (37)

1. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
2. S. Amigorena, C. Bonnerot, D. Choquet, W.H. Fridman, and J. Teillaud FcγRII expression in resting and activated B lymphocytes Eur. J. Immunol. 19 1989 1379 1385
3. R.B. Banati, J. Gehrmann, C. Weissner, K.A. Hossman, and G.W. Kreutzberg Glial expression of the beta-amyloid precursor protein (APP) in global ischemia J. Cereb. Blood Flow Metab. 15 4 1995 647 654
4. B. Brugg, Y.L. Dubreuil, G. Huber, E.E. Wollman, N. Delhaye-Bouchaud, and J. Mariani Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain Proc. Natl. Acad. Sci. 92 7 1995 3032 3035
5. G. DiCarlo, D. Wilcock, D. Henderson, M. Gordon, and D. Morgan Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice Neurobiol. Aging 22 2001 1007 1012
6. M.N. Gordon, W.A. Schreier, X. Ou, L.A. Holcomb, and D.G. Morgan Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat J. Comp. Neurol. 388 1997 106 119
7. M.N. Gordon, L.A. Holcomb, P.T. Jantzen, G. DiCarlo, D. Wilcock, K.W. Boyett, K. Connor, J. Melachrino, J.P. O'Callaghan, and D. Morgan Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse Exp. Neurol. 173 2002 183 195
8. W.S. Griffin, J.G. Sheng, S.M. Gentleman, D.I. Graham, R.E. Mrak, and G.W. Roberts Microglial interleukin-1 alpha expression in human head injury; correlations with neuronal and neuritic beta amyloid precursor protein expression Neurosci. Lett. 176 1994 133 136
9. B. Hauss-Wegrzyniak, and G.L. Wenk Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: the role of ascorbic acid in the vehicle Neurosci. Lett. 322 2002 75 78
10. B. Hauss-Wegrzyniak, P. Dobrzanski, J.D. Stoehr, and G.L. Wenk Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease Brain Res. 780 1998 294 303
11. B. Hauss-Wegrzyniak, L. Lukovic, M. Bigaud, and M.E. Stoeckel Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study Brain Res. 794 1998 211 224
12. B. Hauss-Wegrzyniak, M.G. Vannucchi, and G.L. Wenk Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats Brain Res. 859 2000 157 166
13. B. Hauss-Wegrzyniak, M.A. Lynch, P.D. Vraniak, and G.L. Wenk Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses Exp. Neurol. 176 2002 336 341
14. D. Heumann, and T. Roger Initial responses to endotoxins and Gram-negative bacteria Clin. Chim. Acta 323 2002 59 72
15. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat. Med. 4 1998 97 100
16. J. Husemann, J.D. Loike, R. Anankov, M. Febbraio, and S.C. Silverstein Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system Glia 40 2 2002 195 205
17. B. Kalmar, A. Kittel, R. Lemmens, Z. Kornyei, and E. Madarasz Cultured astrocytes react to LPS with increased cyclooxygenase activity and phagocytosis Neurochem. Int. 38 2001 453 461
18. T. Kawarabayashi, M. Shoji, Y. Harigaya, H. Yamaguchi, and S. Hirai Expression of APP in the early stage of brain damage Brain Res. 563 1991 334 338
19. R. Keller, R. Keist, and P.W. Joller Macrophage response to bacteria and bacterial products: modulation of Fcγ receptors and secretory and cellular activities Immunology 81 1994 161 166
20. G. Laszlo, and H.B. Dickler Regulation of FcγR II expression and function by B lymphocyte activators Mol. Immunol. 27 12 1990 1189 1193
21. A.J. Loughlin, M.N. Woodroofe, and M.L. Cuzner Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation Immunology 75 1992 170 175
22. R.G. Lynch, M. Sandor, T.J. Waldschmidt, A. Mathur, W.T. Schaiff, D.J. Berg, K. Snapp, A. Mueller, M.G. Robinson, N. Noben, and M.G. Rosenberg Lymphocyte Fc receptors: expression, regulation and function Mol. Immunol. 27 12 1990 1167 1179
23. P.L. McGeer, and E.G. McGeer Innate immunity, local inflammation, and degenerative disease Soc. Aging Knowl. Environ. 2002 29
24. K.R. Pennypacker, H. Hernandez, S. Benkovic, D.G. Morgan, A.E. Willing, and P.R. Sanberg Induction of presenilins in the rat brain after middle cerebral arterial occlusion Brain Res. Bull. 48 5 1999 539 543
25. X. Qiao, D.J. Cummins, and S.M. Paul Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse Eur. J. Neurosci. 14 2001 474 482
26. J. Quinn, T. Montine, J. Morrow, W.R. Woodward, D. Kulhanek, and F. Eckenstein Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease J. Neuroimmunol. 137 2003 32 41
27. J.G. Sheng, S.H. Bora, G. Xu, D.R. Borchelt, D.L. Price, and V.E. Koliatsos Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APP transgenic mice Neurobiol. Dis. 14 2003 133 145
28. R. Siman, J.P. Card, R.B. Nelson, and L.G. Davix Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage Neuron 3 1989 275 285
29. L.M. Sly, R.F. Krzesicki, J.R. Brashler, A.E. Buhl, D.D. McKinley, D.B. Carter, and J.E. Chin Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease Brain Res. Bull. 56 2001 581 588
30. M.E. Smith Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE Microsc. Res. Tech. 54 2001 81 94
31. W.J. Streit Microglia as neuroprotective, immunocompetent cells of the CNS Glia 40 2 2002 133 139
32. K. Sugaya, S. Chou, S.J. Xu, and M. McKinney Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin Brain Res. Mol. 58 1-2 1998 1 9
33. C.J. Thomas, M. Kapoor, S. Sharma, H. Bausinger, U. Zyilan, D. Lipsker, D. Hanau, and A. Surolia Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response FEBS Lett. 531 2002 184 188
34. D.M. Wilcock, G. DiCarlo, D. Henderson, J. Jackson, K. Clarke, K.E. Ugen, M.N. Gordon, and D. Morgan Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both dependent and independent of and associated with microglial activation J. Neurosci. 23 9 2003 3745 3751
35. D.M. Wilcock, S.K. Munireddy, A. Rosenthal, K.E. Ugen, M.N. Gordon, and D. Morgan Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration Neurobiol. Dis. 15 2004 11 20
36. L.B. Willard, B. Hauss-Wegrzyniak, and G.L. Wenk Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats Neuroscience 88 1999 193 200
37. K.L. Wright, D.G. Morgan, X. Yu, J.R. Goss, J.M. Salbaum, K. Duff, and M.N. Gordon Mice transgenic for a human amyloid precursor protein promoter-lacZ reporter construct J. Mol. Neurosci. 13 1999 111 120